BCR::ABL1 in patients with CML originates from a cell with intrinsic or acquired biological potential to cause leukemia, such as a CML stem cell (LSC).49, 50. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.